What is Slope?
Founded in 2016 and headquartered in San Francisco, California, Slope offers a sophisticated healthcare software platform designed to prevent inventory outages within clinical trials. The system facilitates real-time coordination between suppliers, clinical sites, and patients, ensuring complete traceability of devices, drugs, and kits. This operational oversight is critical for the efficient and compliant execution of modern clinical research.
How much funding has Slope raised?
Slope has raised a total of $900K across 1 funding round:
Angel/Seed
$900K
Angel/Seed (2017): $900K with participation from Undisclosed
What's next for Slope?
With the recent major strategic investment, Slope is poised for significant growth and expansion. The substantial capital injection, totaling $900K with the latest round adding $900K, will likely be directed towards enhancing its platform capabilities, expanding its market reach within the pharmaceutical and biotech sectors, and potentially scaling its operational infrastructure. This strategic financing signals strong investor confidence in Slope's ability to address complex supply chain challenges in the healthcare industry.
See full Slope company page
